192 related articles for article (PubMed ID: 15222037)
1. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.
Kasper HU; Wolf H; Drebber U; Wolf HK; Kern MA
World J Gastroenterol; 2004 Jul; 10(13):1918-22. PubMed ID: 15222037
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer.
Kong G; Kim EK; Kim WS; Lee KT; Lee YW; Lee JK; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2002 Aug; 17(8):914-21. PubMed ID: 12164968
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
Cianchi F; Cortesini C; Fantappiè O; Messerini L; Sardi I; Lasagna N; Perna F; Fabbroni V; Di Felice A; Perigli G; Mazzanti R; Masini E
Clin Cancer Res; 2004 Apr; 10(8):2694-704. PubMed ID: 15102673
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
Hara A; Okayasu I
Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer.
Franco L; Doria D; Bertazzoni E; Benini A; Bassi C
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):51-8. PubMed ID: 15165031
[TBL] [Abstract][Full Text] [Related]
6. Interaction between cyclooxygenase-2 and inducible nitric oxide synthase in gastric cancer.
Son HJ; Kim YH; Park DI; Kim JJ; Rhee PL; Paik SW; Choi KW; Song SY; Rhee JC
J Clin Gastroenterol; 2001; 33(5):383-8. PubMed ID: 11606854
[TBL] [Abstract][Full Text] [Related]
7. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).
Chiarugi V; Magnelli L; Gallo O
Int J Mol Med; 1998 Dec; 2(6):715-9. PubMed ID: 9850741
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer.
Kong G; Kim EK; Kim WS; Lee YW; Lee JK; Paik SW; Rhee JC; Choi KW; Lee KT
Int J Pancreatol; 2001; 29(3):133-40. PubMed ID: 12067216
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
Wilson KT; Fu S; Ramanujam KS; Meltzer SJ
Cancer Res; 1998 Jul; 58(14):2929-34. PubMed ID: 9679948
[TBL] [Abstract][Full Text] [Related]
10. The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma.
Uotila PJ; Erkkola RU; Klemi PJ
Ann Med; 2002; 34(6):428-33. PubMed ID: 12523498
[TBL] [Abstract][Full Text] [Related]
11. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
[TBL] [Abstract][Full Text] [Related]
14. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
[TBL] [Abstract][Full Text] [Related]
15. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus.
Ribeiro M; Cella M; Farina M; Franchi A
Neuroimmunomodulation; 2004; 11(3):191-8. PubMed ID: 15067210
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma.
Li W; Xu RJ; Jiang LH; Shi J; Long X; Fan B
Med Oncol; 2005; 22(1):63-70. PubMed ID: 15750198
[TBL] [Abstract][Full Text] [Related]
17. Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.
Li HL; Sun BZ; Ma FC
World J Gastroenterol; 2004 Jul; 10(13):1862-6. PubMed ID: 15222024
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer.
Bing RJ; Miyataka M; Rich KA; Hanson N; Wang X; Slosser HD; Shi SR
Clin Cancer Res; 2001 Nov; 7(11):3385-92. PubMed ID: 11705852
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.
Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
